Soliris (eculizumab) is a prescription drug used to treat certain rare autoimmune conditions. Soliris can cause side effects that range from mild to serious. Examples include headache and back pain.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The expanded application makes this the first available ...
Teva and Samsung Bioepis are offering Epysqli, which is is a biosimilar to Alexion Pharmaceuticals' Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic ...
A board investigation found executives at Alexion Pharmaceuticals inappropriately encouraged staff to pressure customers into ordering its drug Soliris earlier than necessary to boost sales, reports ...
Samsung Bioepis and Teva have entered into a license, development and commercialization agreement for Epysqli (eculizumab-aagh), which is Samsung Bioepis’s biosimilar to Soliris. Samsung Bioepis will ...
Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody eculizumab (Soliris, Alexion Pharmaceuticals) for the treatment of neuromyelitis optica spectrum disorder ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Teva Pharmaceutical (NYSE:TEVA) and South Korean generic drugmaker Samsung Bioepis announced Monday the U.S. commercial availability of Epysqli, a biosimilar drug targeting AstraZeneca’s (NASDAQ:AZN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results